3rd, P. W., & A, W. (2005). The development of molecularly targeted anticancer therapies: An Eli Lilly and Company perspective. Clinical advances in hematology & oncology : H&O, 3(3), 199.
Chicago Style (17th ed.) Citation3rd, Perry WL, and Weitzman A. "The Development of Molecularly Targeted Anticancer Therapies: An Eli Lilly and Company Perspective." Clinical Advances in Hematology & Oncology : H&O 3, no. 3 (2005): 199.
MLA (9th ed.) Citation3rd, Perry WL, and Weitzman A. "The Development of Molecularly Targeted Anticancer Therapies: An Eli Lilly and Company Perspective." Clinical Advances in Hematology & Oncology : H&O, vol. 3, no. 3, 2005, p. 199.
Warning: These citations may not always be 100% accurate.
